You have 9 free searches left this month | for more free features.

Leflunomide

Showing 26 - 50 of 172

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 28, 2021

Hepatotoxicity in Rheumatoid Arthritis Through Pharmacokinetic

Completed
  • Rheumatoid Arthritis
  • Leflunomide 20Mg Tab
  • Assiut, Egypt
    Assiut University Hospital
Sep 6, 2020

The Registry Study of Takayasu Arteritis in East China

Recruiting
  • Takayasu Arteritis
  • +4 more
  • Tocilizumab
  • Leflunomide
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021

Leflunomide in Egyptian Active Rheumatoid Arthritis

Completed
  • Active Rheumatoid Arthritis
    • Cairo, Egypt
      Private clinics
    Jun 14, 2020

    Arthritis, Rheumatoid Trial in Belgium (Etanercept 50 MG/ML, Leflunomide 10 milligram (MG))

    Completed
    • Arthritis, Rheumatoid
    • Etanercept 50 MG/ML
    • Leflunomide 10 milligram (MG)
    • Bonheiden, Antwerpen, Belgium
    • +18 more
    Jul 4, 2022

    Glomerulonephritis, IGA, Renal Insufficiency, Chronic Trial in Shenzhen (Leflunomide 20 mg+prednisone 0.5mg/kg/d)

    Unknown status
    • Glomerulonephritis, IGA
    • Renal Insufficiency, Chronic
    • Leflunomide 20 mg+prednisone 0.5mg/kg/d
    • Shenzhen, Guangdong, China
      Xu Yi
    Feb 14, 2020

    Kidney Transplant Infection, BK Virus Infection Trial in Bangkok (Everolimus, reduced dose tacrolimus)

    Recruiting
    • Kidney Transplant Infection
    • BK Virus Infection
    • Bangkok, Thailand
      King Chulalongkorn Memorial Hospital
    Nov 10, 2022

    (CHOIR)

    Recruiting
    • Chronic Nonbacterial Osteomyelitis
    • Chronic Recurrent Multifocal Osteomyelitis
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 25, 2021

    Smoldering Plasma Cell Myeloma Trial in Duarte (Leflunomide, Quality-of-Life Assessment, Questionnaire Administration)

    Withdrawn
    • Smoldering Plasma Cell Myeloma
    • Leflunomide
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 12, 2019

    Rheumatoid Arthritis Trial in Chicago (Lab Work, Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of

    Completed
    • Rheumatoid Arthritis
    • Lab Work
    • +11 more
    • Chicago, Illinois
      Outpatient Care Center
    Jul 13, 2020

    Rheumatoid Arthritis Trial in Cairo (Cilostazol 100 MG, conventional synthetic antirheumatic drugs)

    Recruiting
    • Rheumatoid Arthritis
    • Cilostazol 100 MG
    • conventional synthetic antirheumatic drugs
    • Cairo, Egypt
      Al-Zahraa Hospital
    Dec 26, 2022

    Henoch-Schoenlein Purpura Nephritis Trial in Nanjing (Prednisone, Cyclophosphamide(CTX), Mycophenolate mofetil(MMF))

    Unknown status
    • Henoch-Schoenlein Purpura Nephritis
    • Nanjing, Jiangsu, China
      Nanjing Children's Hospital
    Feb 25, 2020

    T and B Cell Repertoire Changes in Response to Orencia® in

    Recruiting
    • Rheumatoid Arthritis
      • New York, New York
        Hospital for Special Surgery
      Mar 13, 2023

      Polymyalgia Rheumatica Trial in Almelo, Groningen (Leflunomide 20 mg, Prednisolone)

      Unknown status
      • Polymyalgia Rheumatica
      • Almelo, Netherlands
      • +1 more
      May 30, 2019

      Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

      Completed
      • Rheumatoid Arthritis
      • Pondicherry, Pondicherry UT, India
        Jawaharlal Institute of Postgraduate Medical Education & Researc
      Sep 28, 2019

      Immunoglobulin G4 Related Sclerosing Disease Trial in Beijing (Prednisone, Leflunomide)

      Completed
      • Immunoglobulin G4 Related Sclerosing Disease
      • Beijing, China
        Chinese PLA General Hospital
      Mar 4, 2019

      Mechanistic Studies of Teriflunomide in RRMS

      Active, not recruiting
      • Relapsing Remitting Multiple Sclerosis
      • Ann Arbor, Michigan
        University of Michigan
      Jul 27, 2022

      Monitoring of Inflammatory Conditions

      Recruiting
      • Inflammatory Disease
      • +8 more
      • Questionnaire
      • Semi-structured interview
      • Nottingham, Nottinghamshire, United Kingdom
        University of Nottingham
      Jul 11, 2022

      Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)

      Not yet recruiting
      • Connective Tissue Diseases
      • Thrombocytopenia
      • Telitacicept
      • Placebo
      • Hefei, Anhui, China
      • +21 more
      Aug 18, 2023

      Power Doppler in Hand Joints of Early RA Patients

      Completed
      • Early Rheumatoid Arthritis
      • Drug protocol
      • (no location specified)
      Feb 15, 2021

      Rheumatoid Arthritis Trial in Mansoura (Montelukast, Placebo, Conventional DMARDs)

      Not yet recruiting
      • Rheumatoid Arthritis
      • Mansoura, Egypt
        Mansoura University
      Jul 1, 2022

      Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))

      Not yet recruiting
      • Rheumatoid Arthritis
      • Abatacept (M3-M12)
      • +2 more
      • Montpellier, France
        Centre Hospitalier Universitaire de Montpellier
      Jun 16, 2022

      Inflammatory Bowel Disease Related Joint Manifestations

      Not yet recruiting
      • IBD
      • Joint Diseases
        • (no location specified)
        Jan 12, 2023

        Autoimmune Disease Trial in Beijing (Prednisone, Prednisone and Leflunomide)

        Unknown status
        • Autoimmune Disease
        • Beijing, Beijing, China
          Yunyun Fei
        Oct 21, 2018

        COVID-19 Trial in Australia (diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine)

        Not yet recruiting
        • COVID-19
        • diphtheria and tetanus toxoids (adsorbed) vaccine
        • COVID-19 vaccine
        • Blacktown, New South Wales, Australia
        • +4 more
        Nov 20, 2022